Brokerages Set RxSight, Inc. (NASDAQ:RXST) Target Price at $49.63

RxSight, Inc. (NASDAQ:RXST – Get Free Report) has earned an average recommendation of “Buy” from the six ratings firms that are currently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued ratings on the stock in the last […]

Related Keywords

United States ,Stifel Nicolaus ,Eric Weinberg ,Blackrock Inc ,York Mellon Corp ,Needham Company ,Vanguard Group Inc ,Securities Exchange Commission ,Rxsight Inc ,Jpmorgan Chase Co ,Nasdaq ,Get Free Report ,Director William ,Exchange Commission ,New York Mellon Corp ,Vanguard Group ,Sight Trading Down ,Get Free ,Rxsight Daily ,Rxsight ,Nasdaq Rxst ,Rxst ,Medical ,Ratings ,Consensus ,